Moderna fourth-quarter revenue beats estimates

Investing.com -- Moderna Inc (NASDAQ: MRNA) has reported a steep drop in fourth-quarter revenue to $2.81 billion, but still topped average analyst expectations.

Shares in the U.S. drugmaker were higher in premarket trading on Thursday.

This is a developing story. Please check back later for updates.

You May Also Be Interested In

• Academy Sports surges on earnings beat and raised guidance
• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance